Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5956802 | 0.98 | — | — | |
| Iodide SCHEMBL30138840 | 0.77 | — | — | |
| SCHEMBL28479681 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL28516881 | 0.73 | — | — | |
| Bromide SCHEMBL28157820 | 0.73 | — | — | |
| Iodide SCHEMBL27477455 | 0.72 | — | — | |
| SCHEMBL7849374 | 0.71 | — | — | |
| SCHEMBL28824489 | 0.70 | — | — | |
| SCHEMBL28166479 | 0.70 | — | — | |
| SCHEMBL27666909 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116987025-B | Crystal form of pralidoxime chloride and preparation method thereof | 成都瑞尔医药科技有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117003689-A | Crystal form of iodophosphate and preparation method thereof | 成都瑞尔医药科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116987025-A | Crystal form of pralidoxime chloride and preparation method thereof | 成都瑞尔医药科技有限公司 | 2023-11-03 | — | — | CN | disclosed |
| US-7919493-B2 | A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent | PHARMA MAR, S.A. (ES) | 2011-04-05 | — | — | US | disclosed |
| US-20080146580-A1 | Anititumoral Ecteinascidin Derivatives | PHARMAMAR (ES) | 2008-06-19 | — | — | US | disclosed |